FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer

被引:53
作者
Lin, Lilie L.
Yang, Zhiyun
Mutic, Sasa
Miller, Tom R.
Grigsby, Perry W.
机构
[1] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63130 USA
[2] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA
[3] Mallinckrodt Inst Radiol, Dept Radiol, Div Nucl Med, St Louis, MO 63110 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 65卷 / 01期
关键词
positron emission tomography; cervix; FDG-PET; tumor volume;
D O I
10.1016/j.ijrobp.2005.12.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the physiologic tumor volume response during treatment in cervical cancer using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). Patients and Methods: This was a prospective study of 32 patients. Physiologic tumor volume in cubic centimeters was determined from the FDG-PET images using the 40% threshold method. Results: The mean pretreatment tumor volume was 102 cm(3). The mean volume by clinical Stages I, II, and III were 54, 79, and 176 cm(3), respectively. After 19.8 Gy external irradiation to the pelvis, the reduction in tumor was 29% (72 cm(3)). An additional 13 Gy from high-dose-rate (HDR) brachytherapy reduced the mean to 15.4 cm(3), and this was subsequently reduced to 8.6 cm(3) with 13 Gy additional HDR brachytherapy (26 Gy, HDR). Four patients had physiologic FDG uptake in the cervix at 3 months after the completion of therapy. The mean time to the 50% reduction in physiologic tumor volume was 19.9 days and after combined external irradiation and HDR to 24.9 Gy. Conclusion: These results indicate that physiologic tumor volume determination by FDG-PET is feasible and that a 50% physiologic tumor volume reduction occurs within 20 days of starting therapy. (c) 2006 Elsevier Inc.
引用
收藏
页码:177 / 181
页数:5
相关论文
共 31 条
[1]   Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer [J].
Avril, N ;
Sassen, S ;
Schmalfeldt, B ;
Naehrig, J ;
Rutke, S ;
Weber, WA ;
Werner, M ;
Graeff, H ;
Schwaiger, M ;
Kuhn, W .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7445-7453
[2]   FIGO Special Report on Gynecologic Cancer 2000 [J].
Benedet, JL .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 70 (02) :207-208
[3]   THE INFLUENCE OF TUMOR SIZE AND MORPHOLOGY ON THE OUTCOME OF PATIENTS WITH FIGO STAGE IB SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX [J].
EIFEL, PJ ;
MORRIS, M ;
WHARTON, JT ;
OSWALD, MJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (01) :9-16
[4]   Use of PET to monitor the response of lung cancer to radiation treatment [J].
Erdi, YE ;
Macapinlac, H ;
Rosenzweig, KE ;
Humm, JL ;
Larson, SM ;
Erdi, AK ;
Yorke, ED .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (07) :861-866
[5]  
Grigsby Perry W., 1999, Clin Positron Imaging, V2, P105, DOI 10.1016/S1095-0397(99)00008-4
[6]   Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix:: Response and outcome [J].
Grigsby, PW ;
Siegel, BA ;
Dehdashti, F ;
Rader, J ;
Zoberi, I .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2167-2171
[7]   Lymph node staging by positron emission tomography in patients with carcinoma of the cervix [J].
Grigsby, PW ;
Siegel, BA ;
Dehdashti, F .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (17) :3745-3749
[8]   PROGNOSTIC SIGNIFICANCE OF TUMOR RESPONSE DURING RADIOTHERAPY IN CERVICAL CARCINOMA [J].
GROSSMAN, I ;
KUROHARA, SS ;
WEBSTER, JH ;
GEORGE, FW .
RADIOLOGY, 1973, 107 (02) :411-415
[9]  
HARDT N, 1982, CANCER, V49, P35, DOI 10.1002/1097-0142(19820101)49:1<35::AID-CNCR2820490108>3.0.CO
[10]  
2-3